Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S2 pseudogene 32 (RPS2P32) is part of a large family of processed pseudogenes related to ribosomal protein genes in the human genome. These pseudogenes share high sequence similarity with their functional counterparts (such as RPS2, which encodes a component of the 40S ribosomal subunit essential for protein synthesis), but RPS2P32 does not encode a functional protein. The creation and genomic scattering of ribosomal protein pseudogenes is common, with hundreds identified throughout the human genome, arising mainly from retrotransposition events. While some pseudogenes display evidence of transcription or play regulatory roles in rare cases, there is no evidence that RPS2P32 has such function. It is not a therapeutic target, lacks known associations with disease or drug interaction, and holds no established clinical or biological significance.
Not applicable; not a drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S2 pseudogene 32 (RPS2P32).